Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Safety and Financial Analysis of Outpatient Hypercvad Arm a Administration for Acute Lymphoblastic Leukemia

Yujiao Sun, Ariel Denson, Katherine Tobon, Rebecca Jean Nelson, Amber Lubas, Bijal D. Shah, Timothy Kubal, Christopher Rodriguez Salamanca, Jad Chahoud, Javier Pinilla-Ibarz, Leidy Lismeris Isenalumhe

Blood (2023) 142 (Supplement 1): 2343.

https://doi.org/10.1182/blood-2023-187050

Published: 2023

Journal Articles

The Impact of 20q Deletion on Clinical Presentation, Treatment Response and Survival in Patients with Acute Myeloid Leukemia (AML): The University of Texas MD Anderson Cancer Center Experience

Jad Chahoud, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Tapan Kadia, MD, Mark Brandt, BS, Elias Jabbour

Blood (2015) 126 (23): 1369.

https://doi.org/10.1182/blood.V126.23.1369.1369

Published: 2015

Journal Articles

Outcomes of Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphocytic Leukemia (ALL) Post Blinatumomab Failure

Jenny Dahl, PA, Hagop M. Kantarjian, MD, Musa Yilmaz, MD, Tapan Kadia, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Jorge E. Cortes, MD, Alessandra Ferrajoli, MD, Koji Sasaki, MD, Jad Chahoud, MD, Jane Autry, RN, Rebecca Garris, Elias Jabbour

Blood (2015) 126 (23): 1335.

https://doi.org/10.1182/blood.V126.23.1335.1335

Published: 2015

Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL) after Failure of Inotuzumab Ozogamicin

Jad Chahoud, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Koji Sasaki, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Maria R. Khouri, Farhad Ravandi, MD, Jenny Dahl, PA, Alessandra Ferrajoli, MD, Jovitta Jacob, RN, Naveen Pemmaraju, MD, Naval Daver, MD, Rebecca Garris, Elias Jabbour

Blood (2015) 126 (23): 1298.

https://doi.org/10.1182/blood.V126.23.1298.1298

Published: 2015

Journal Articles

Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)

Koji Sasaki, MD, Paul B. Koller, MD, Hagop M. Kantarjian, MD, Deborah A Thomas, MD, Maria R. Khouri, Guillermo Garcia-Manero, MD, Rebecca Garris, Jorge E. Cortes, MD, Heather Schroeder, Jad Chahoud, MD, Tapan Kadia, MD, Farhad Ravandi, MD, Srdan Verstovsek, MD PhD, Naval Daver, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Susan O'Brien, MD, Elias Jabbour

Blood (2015) 126 (23): 1295.

https://doi.org/10.1182/blood.V126.23.1295.1295

Published: 2015

Journal Articles

Frontline Hyper-CVAD with Ponatinib for Patients (pts) with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Results of a Phase II Study

Koji Sasaki, MD, Susan O'Brien, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Haim G Moore, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Musa Yilmaz, MD, Tapan Kadia, MD, Rebecca Garris, Guillermo Garcia-Manero, MD, Twilla Victoria Jeanis, RN, Jad Chahoud, MD, Gautam Borthakur, MD, William Wierda, MD PhD, Alessandra Ferrajoli, MD, Hagop M. Kantarjian, MD, Elias Jabbour

Blood (2015) 126 (23): 2496.

https://doi.org/10.1182/blood.V126.23.2496.2496

Published: 2015

Journal Articles

Idarubicin and Cytarabine Combined with Clofarabine or Fludarabine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: Interim Result of a Phase II Clinical Trial

Paul B. Koller, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Susan O'Brien, MD, Jorge E. Cortes, MD, Tapan Kadia, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Jad Chahoud, MD, Allison Pike, RN, Mark Brandt, BS, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Elias Jabbour

Blood (2015) 126 (23): 2508.

https://doi.org/10.1182/blood.V126.23.2508.2508

Published: 2015

Journal Articles

Liposomal Vincristine (Marqibo) Combined with Hyper-Cmad As Frontline Therapy for Patients with Acute Lymphoblastic Leukemia: A Result of a Phase II Clinical Trial

Koji Sasaki, MD, Elias Jabbour, Deborah A Thomas, MD, Maria R. Khouri, Musa Yilmaz, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Rebecca Garris, Evguenia Gachimova, BSN, RN, Jad Chahoud, MD, Courtney DiNardo, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, Hagop M. Kantarjian, MD, Susan O'Brien, MD

Blood (2015) 126 (23): 3720.

https://doi.org/10.1182/blood.V126.23.3720.3720

Published: 2015

Journal Articles

Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Jorge Cortes, Guillermo Garcia-Manero, MD, Jad Chahoud, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Koichi Takahashi, MD, William G. Wierda, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Elias Jabbour

Blood (2015) 126 (23): 3722.

https://doi.org/10.1182/blood.V126.23.3722.3722

Published: 2015

NARROW

Safety and Financial Analysis of Outpatient Hypercvad Arm a Administration for Acute Lymphoblastic Leukemia

The Impact of 20q Deletion on Clinical Presentation, Treatment Response and Survival in Patients with Acute Myeloid Leukemia (AML): The University of Texas MD Anderson Cancer Center Experience

Outcomes of Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphocytic Leukemia (ALL) Post Blinatumomab Failure

Outcome of Patients with Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (ALL) after Failure of Inotuzumab Ozogamicin

Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)

Frontline Hyper-CVAD with Ponatinib for Patients (pts) with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Results of a Phase II Study

Idarubicin and Cytarabine Combined with Clofarabine or Fludarabine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: Interim Result of a Phase II Clinical Trial

Liposomal Vincristine (Marqibo) Combined with Hyper-Cmad As Frontline Therapy for Patients with Acute Lymphoblastic Leukemia: A Result of a Phase II Clinical Trial

Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only